Zevra Therapeutics

Zevra Therapeutics

Targeting improved therapies for pain, ADHD and other CNS indications.

Launch date
Employees
Market cap
CAD545m
Enterprise valuation
CAD559m (Public information from Sep 2024)
Kissimmee Florida (HQ), Coralville Iowa (founding location)
Authorizing premium user...